Journal
PNEUMONIA
Volume 13, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s41479-021-00092-9
Keywords
COVID-19; Acute respiratory distress syndrome; SARS-CoV-2; Pandemics; ARDS
Categories
Ask authors/readers for more resources
The COVID-19 pandemic is a serious issue in the new era, with a focus on controlling lung diseases such as ARDS and lung failure. Ongoing research is crucial, with current emphasis on managing COVID-19 patients and evaluating treatment strategies for ARDS induced by COVID-19.
COVID-19 pandemic is a serious concern in the new era. Acute respiratory distress syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even though COVID-19 vaccinations are available now, there is still an urgent need to find potential treatments to ease the effects of COVID-19 on already sick patients. Multiple experimental drugs have been approved by the FDA with unknown efficacy and possible adverse effects. Probably the increasing number of studies worldwide examining the potential COVID-19 related therapies will help to identification of effective ARDS treatment. In this review article, we first provide a summary on immunopathology of ARDS next we will give an overview of management of patients with COVID-19 requiring intensive care unit (ICU), while focusing on the current treatment strategies being evaluated in the clinical trials in COVID-19-induced ARDS patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available